New cancer clinical trial: A Phase Ib Trial of Cabozantinib in Combination With Durvalumab (MEDI4736) in Previously Treated Patients With Advanced Gastroesophageal Cancer and Other Gastrointestinal (GI) Malignancies (CAMILLA)

Published on: May 28, 2018 at 12:00PM
Conditions:   Gastric Cancer;   Esophageal Adenocarcinoma;   Hepatocellular Carcinoma;   Colorectal Cancer
Interventions:   Drug: Cabozantinib;   Drug: Durvalumab
Sponsors:   Anwaar Saeed;   AstraZeneca;   Exelixis
Not yet recruiting
https://ift.tt/2JiBkRW